Abstract LB460: Characterization of ARTS-051, a potent and selective Werner helicase inhibitor effective against a broad range of MSI-H colorectal cancer models
Christine Moomau(Cytori Therapeutics (United States)), Xiang Zhai(Cytori Therapeutics (United States)), David B. Pirovich(Cytori Therapeutics (United States)), Yipin Lu(Cytori Therapeutics (United States)), Tao Ji(Cytori Therapeutics (United States)), Lina Gu(Cytori Therapeutics (United States)), Wenheng Liang(Bioscience (China)), Fang Li(Cytori Therapeutics (United States)), Jiaqi Liang(Bioscience (China)), John Campbell(Cytori Therapeutics (United States)), Xiaozhi Yang(Sun Yat-sen University), Jian Lin(Cytori Therapeutics (United States)), Yaoyu Chen(Wuhan Institute of Physics and Mathematics)
Cited by 0
Related Papers
Nano-palladium is a cellular catalyst for in vivo chemistry
|Nature Communications|2017|288
Multifunctional Fructose 1,6-Bisphosphate Aldolase as a Therapeutic Target
|Frontiers in Molecular Biosciences|2021|110
Supramolecular Metallo‐Bioadhesive for Minimally Invasive Use
|Advanced Materials|2016|83
Targeting <i>HSF1</i> sensitizes cancer cells to HSP90 inhibition
|Oncotarget|2013|59